Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
Hou ZJ, Luo X, Zhang W, Peng F, Cui B, Wu SJ, Zheng FM, Xu J, Xu LZ, Long ZJ, Wang XT, Li GH, Wan XY, Yang YL, Liu Q.
Hou ZJ, et al. Among authors: wang xt.
Oncotarget. 2015 Mar 20;6(8):6326-40. doi: 10.18632/oncotarget.3436.
Oncotarget. 2015.
PMID: 25811972
Free PMC article.